Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids. Codeine, morphine, hydrocodone, oxycodone, heroin, and fentanyl are some of the major prescription drugs in the global opioids agonist drugs market. Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges. Overdose and drug abuse is a major concern for health regulators worldwide, with the situation especially alarming in developed regions with easy access to these drugs. According to the World Drug Report 2016, a staggering 17.4 million people were affected by opioid drug abuse. Drug and health regulators are therefore, taking initiatives to govern pain prescriptions and curb the rate of opioid abuse. The U.S. FDA considers all opioids as schedule 2 drugs—drugs that have high abuse potential. In 2016, the CDC issued guidelines to prescribe opioids, limiting the daily dose of opioids to 90 morphine milligram equivalent (MME).
Market Dynamics
According to the National Institutes of Health (NIH) estimates published in 2015 by the American Pain Society, nearly 50 million people in the U.S. suffered from chronic pain. Use of opioids in cancer pain, orthopedic pain, neuropathic pain, post-operative pain, and lower back pain is very effective. With growing incidence of chronic pain, demand for opioids will also increase consequently.
North America is the largest market for opioids owing to availability of branded prescription and local products, which inadvertently also leads to drug abuse. There are local unbranded products available for every opioid derivative complementing the available prescription opioid brand. The Centers for Disease Control and Prevention (CDC) states that 73% of all drug overdose deaths in the U.S. in 2015 were due to opioids (57% in 2010). Moreover, emergence of cannabis as an alternative to opioids and legalization of the same in various regions is inhibiting the opioids market growth.
Market Taxonomy
This report segments the global opioids agonist drugs on the basis of drug type, application, and geography. On the basis of drug type, the global opioids market is categorized into codeine, morphine, fentanyl, methadone and hydrocodone. On the basis of application, the market is segmented into pain management, diarrhea and cough treatment. Pain Management is further segmented into Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others. For comprehensive understanding of market dynamics, the global opioids market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
- This report provides in-depth analysis of the opioids products and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global opioids agonist drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Purdue Pharma L.P., Janssen Pharmaceuticals, Inc., West - Ward Pharmaceuticals Corporation, Pfizer, Inc., Egalet Corporation, Allergan plc, Sanofi SA, Boehringer Ingelheim, and Sun Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
- The global opioids agonist drugs market report caters to various stakeholders in this industry, including investors, manufacturers and distributors for opioid products, health and regulatory agencies, research and consulting firms, new entrants, and financial analysts
- Various strategy matrices used in analyzing the opioids market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
- Global Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Global Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Global Opioids Agonist Drugs Market, By Geography:
- North America
- U.S.
- U.S. Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- U.S. Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Canada
- Canada Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Canada Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Europe
- U.K.
- U.K. Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- U.K. Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Germany
- Germany Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Germany Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Italy
- Italy Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Italy Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- France
- France Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- France Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Spain
- Spain Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Spain Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Russia
- Russia Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Russia Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Rest of Europe
- Rest of Europe Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Rest of Europe Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Asia-Pacific
- China
- China Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- China Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- India
- India Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- India Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Japan
- Japan Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Japan Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- ASEAN
- ASEAN Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- ASEAN Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Australia
- Australia Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Australia Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- South Korea
- South Korea Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- South Korea Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Rest of Asia Pacific (APAC)
- Rest of Asia Pacific Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Rest of Asia Pacific Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Latin America
- Brazil
- Brazil Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Brazil Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Mexico
- Mexico Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Mexico Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Rest of Latin America
- Rest of Latin America Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Rest of Latin America Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Middle East
- GCC
- GCC Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- GCC Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Israel
- Israel Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Israel Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Rest of Middle East
- Rest of Middle East Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Rest of Middle East Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Africa
- North Africa
- North Africa Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- North Africa Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Central Africa
- Central Africa Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Central Africa Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- South Africa
- South Africa Opioids Agonist Drugs Market, By Product Type:
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- South Africa Opioids Agonist Drugs Market, By Therapeutic Application:
- Pain Management
- Neuropathic Pain
- Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
- Company Profiles
- Purdue Pharma*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Titan pharmaceuticals
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc.
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.
- Allergan, Plc
- Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.
